Home›Research›Compare›Davunetide vs Semax
Peptide ComparisonDavunetide vs Semax
Both are Neuro & Cognitive peptides.
Semax
ACTH(4-10) analogue
Half-life: 20–30 minutes (intranasal)
168 providers listed
Davunetide has published research citations on file; Semax does not yet — the main evidence gap between them.
Davunetide
Half-life
—
Semax
Half-life
20–30 minutes (intranasal)
| Your goal | Better option |
|---|---|
| Has published research citations | Davunetide |
| Further along in FDA review | Davunetide |
| More provider options (0 vs 168) | Semax |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Davunetide
Semax
Davunetide
Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with sch…
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophren…
Microtubule-stabilizing drugs suppress convulsions in a C. elegans model of CAMSAP disorders.
Semax
No citations on file.
About Davunetide
Stabilizes microtubules by interacting with tubulin and microtubule-associated proteins. Activates SIRT1, reduces amyloid-β toxicity, and enhances synaptic plasticity. Protects against tau hyperphosphorylation.
About Semax
Semax is believed to upregulate brain-derived neurotrophic factor (BDNF) and other neuroprotective factors, enhancing neuronal survival and synaptic plasticity. It modulates the dopaminergic and serotonergic systems, contributing to its reported effects on mood and focus. Its mechanism of action differs from classical stimulants — it does not act on adrenergic receptors and does not produce typical stimulant tolerance or dependence patterns.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Davunetide
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Semax
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Semax
Selank
Research suggests Semax and Selank may produce complementary cognitive and stress-modulating effects when combined. Semax is studied for BDNF upregulation and cognitive enhancement, while Selank is studied for anxiolytic and immune-regulatory activity — distinct mechanisms with potential overlap in neuroprotective signaling.
Davunetide
Not enough vendor pricing yet.
Semax
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Neuro & Cognitive Comparisons
Browse all peptides →Explore Davunetide
Explore Semax
Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Davunetide vs Semax — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/davunetide/semax